Biotechnology executive with 20 years of experience driving innovation, regulatory success, and commercialization of advanced therapies. Proven track record leading global CMC, MSAT, and GMP operations across cell therapy, viral vectors, and biologics. Recognized for building high-performing teams, securing IND/BLA approvals, and delivering multi-million-dollar process improvements that accelerate time-to-market and ensure patient access. An effective leader dedicated to empowering and developing personnel, ensuring a culture of growth and excellence.